Expand LUMO Menu
LUMO MENU

LUMO Latest Press Releases

-- December 12, 2024 --

Lumos Pharma and Double Point Ventures Announce Successful Completion of Tender Offer and Double Point Ventures' Acquisition of Lumos Pharma Globe Newswire 8:47 AM

-- November 21, 2024 --

Updated Phase 2 OraGrowtH Data Presented at ESPE 2024 Demonstrate Sustained Growth on Oral LUM-201 to 24 Months in PGHD and Correlation of Growth to LUM-201's Unique Pulsatile Mechanism of Action Globe Newswire 9:00 AM

-- November 16, 2024 --

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LUMO, PIK, OB on Behalf of Shareholders Globe Newswire 11:14 AM

-- November 12, 2024 --

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LUMO, ALTR, STAF on Behalf of Shareholders PRNewswire 3:27 PM
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LUMO, ALTR, STAF on Behalf of Shareholders PRNewswire 3:27 PM

-- November 6, 2024 --

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LUMO, PIK, INSI on Behalf of Shareholders Globe Newswire 6:48 PM

-- October 30, 2024 --

Lumos Pharma Announces Two Abstracts Accepted for Oral Presentation at the 62n? Annual ESPE Meeting 2024 Globe Newswire 4:05 PM

-- October 28, 2024 --

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LUMO, BMTX, NXU on Behalf of Shareholders PRNewswire 12:27 PM

-- October 24, 2024 --

INVESTIGATION ALERT: Halper Sadeh LLC Continues to Investigate MMLP, FSHP, ICCH, and LUMO on Behalf of Shareholders Globe Newswire 11:31 AM
Kuehn Law Encourages MMLP, ICCH, FSHP, and LUMO Investors to Contact Law Firm Globe Newswire 9:50 AM

-- October 23, 2024 --

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Lumos Pharma, Inc. PRNewswire 3:51 PM
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MMLP and LUMO on Behalf of Shareholders PRNewswire 3:31 PM
LUMO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Lumos Pharma, Inc. Is Fair to Shareholders Business Wire 10:28 AM
Shareholder Alert: Ademi LLP Investigates Whether Lumos Pharma, Inc. Is Obtaining a Fair Price for Its Public Shareholders Business Wire 8:59 AM
Lumos Pharma Enters into Definitive Merger Agreement with Double Point Ventures to Go Private via a Tender Offer of $4.25 Cash per Share Plus Contingent Value Rights (CVR) Globe Newswire 8:00 AM

-- September 25, 2024 --

Lumos Pharma Announces Abstract Accepted for Oral Presentation at the 13th Biennial Scientific Meeting of the Asia Pacific Pediatric Endocrine Society, APPES 2024 Globe Newswire 4:05 PM

-- September 5, 2024 --

Lumos Pharma Announces Abstract Accepted for Presentation at September Medical Meeting, SLEP 2024 Globe Newswire 9:00 AM

-- August 15, 2024 --

Lumos Pharma to Participate in H.C. Wainwright 26th Annual Global Investment Conference Globe Newswire 9:00 AM

-- August 1, 2024 --

Lumos Pharma Reports Second Quarter 2024 Financial Results and Provides Clinical Development Update Globe Newswire 4:05 PM

-- July 23, 2024 --

Lumos Pharma to Report Second Quarter 2024 Financial Results and Provide Clinical Update on August 1, 2024 Globe Newswire 4:05 PM